Valuation of biotech/medtech and R&D assets, from discovery to late clinical stage. Strong strategic insight: asset/company stage of readiness - Value of science vs. value of cash - Dealmaking & patterns - Applications: Fundraising, IPO, BD&L partnering, IFRS, US-GAAP, tax-related fairness opinion.